Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

A 4015Sesión 221

Qué cambió entre versiones

11 párrafos cambiaron+59 palabras agregadas−106 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

[First Reprint]

ASSEMBLY, No. 4015

5 párrafos sin cambios

STATE OF NEW JERSEY

221st LEGISLATURE

INTRODUCED MARCH 7, 2024

Sponsored by:

Assemblywoman TENNILLE R. MCCOY

District 14 (Mercer and Middlesex)

Co-Sponsored by:

Assemblywoman Reynolds-Jackson, Assemblyman Miller, Assemblywoman Hall and Assemblyman Bailey

SYNOPSIS

Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

CURRENT VERSION OF TEXT

As introduced.

As reported by the Assembly Financial Institutions and Insurance Committee on May 15, 2025, with amendments.

An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.).

Be It Enacted by the Senate and General Assembly of the State of New Jersey:

1. a. A pharmacy practice site shall:

(1) display 1 , in a conspicuous manner on the website of the pharmacy, 1 a notice concerning insulin manufacturer assistance programs, to be created by the Department of 1 [ Banking and Insurance, at all points of sale ] Health 1 ; and

(2) 1 at the individual’s request, 1 provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet.

b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets.

c. The department shall adopt rules and regulations pursuant to the “Administrative Procedure Act,” P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act.

2. This act shall take effect on the first day of the 1 [ sixth ] twelfth 1 month next following the date of enactment, except that the Commissioner of 1 [ Banking and Insurance ] Health 1 may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act.

STATEMENT

This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

Under this bill, a pharmacy practice site will be required to display a notice, created by the Department of Banking and Insurance, concerning insulin manufacturer assistance programs at all points of sale. A pharmacy practice site will also be required to provide a pamphlet, created by the department, concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.

Volver al texto completo